CLBZ · As filed with the SEC
Collab Z balance sheet, by quarter
The statement as Collab Z presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Condensed Consolidated Balance Sheets (Unaudited) · USD
| USD | Q2 FY26 Mar 31, 2026 | Q1 FY26 Dec 31, 2025 | Q4 FY25 Sep 30, 2025 |
|---|---|---|---|
| ASSETS | |||
| Current assets: | |||
| Cash | 10,794 | 250,904 | 161,506 |
| Restricted cash | 2,762,575 | — | — |
| Related Parties | 586,227 | 468,359 | 266,580 |
| Accounts receivable | 489,684 | 186,619 | 86,972 |
| Due from related parties | 420,578 | 424,388 | 383,577 |
| Prepaid expenses and other current assets | 5,587 | 14,262 | 13,933 |
| Subscription receivable | — | — | 150,000 |
| Loan receivable | 314,668 | 310,414 | 552,059 |
| Total current assets | 4,590,113 | 1,654,946 | 1,614,627 |
| Deferred offering costs | 720,764 | 673,264 | 619,925 |
| Investment in joint venture | 57,237 | 59,991 | 57,753 |
| Intangible assets, net | 301,504 | 254,237 | 198,178 |
| Total assets | 5,669,618 | 2,642,438 | 2,490,483 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||
| Current liabilities: | |||
| Accounts payable and accrued expenses | 498,447 | 413,872 | 376,961 |
| Deferred revenue | 35,000 | 35,000 | 35,000 |
| Due to related parties | 30,001 | 26,937 | 16,605 |
| Dividend payable | 25,577 | 25,479 | — |
| Total current liabilities | 589,025 | 501,288 | 428,566 |
| Future equity obligations | 25,000 | 25,000 | 25,000 |
| Total liabilities | 614,025 | 526,288 | 453,566 |
| Mezzanine equity: | |||
| Common stock subject to possible redemption, $0.001 par value, 60,000 shares issued and outstanding as of both March 31, 2026 and September 30, 2025, respectively | 120,000 | 120,000 | 120,000 |
| Redeemable convertible preferred stock, $0.001 par value, 10,000,000 shares authorized, 1,250,000 designated as Series C; 688,250 and 0 shares issued and outstanding as of March 31, 2026 and September 30, 2025, respectively | 2,792,615 | — | — |
| Stockholders’ equity: | |||
| Series B | 200 | 200 | 200 |
| Series X | 5 | 5 | 5 |
| Common stock, $0.001 par value, 190,000,000 shares authorized, 5,091,391 shares issued and outstanding as of both March 31, 2026 and September 30, 2025 | 5,092 | 5,092 | 5,092 |
| Additional paid-in capital | 1,164,513 | 1,154,513 | 1,144,513 |
| Retained earnings | 973,168 | 836,340 | 767,107 |
| Total stockholders’ equity | 2,142,978 | 1,996,150 | 1,916,917 |
| Total liabilities, mezzanine equity and stockholders’ equity | 5,669,618 | 2,642,438 | 2,490,483 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.